Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018158459) ORODISPERSIBLE TABLET CONTAINING BURLULIPASE AND PHARMACEUTICAL COMPOSITION PRODUCED THEREFROM
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/158459 International Application No.: PCT/EP2018/055285
Publication Date: 07.09.2018 International Filing Date: 05.03.2018
IPC:
A61K 9/20 (2006.01) ,A61K 38/16 (2006.01) ,A61K 9/10 (2006.01) ,A61K 9/107 (2006.01) ,A61K 47/46 (2006.01) ,A61P 1/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
107
Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
46
Ingredients of undetermined constitution or reaction products thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
18
for pancreatic disorders, e.g. pancreatic enzymes
Applicants:
NORDMARK ARZNEIMITTEL GMBH & CO. KG [DE/DE]; Pinnauallee 4 25436 Uetersen, DE
Inventors:
FUHRHERR, Richard; DE
LÜDEMANN, Jan; DE
GARRETT, Lisa; GB
Agent:
RGTH PATENTANWÄLTE PARTGMBB; Neuer Wall 10 20354 Hamburg, DE
Priority Data:
10 2017 104 472.803.03.2017DE
Title (EN) ORODISPERSIBLE TABLET CONTAINING BURLULIPASE AND PHARMACEUTICAL COMPOSITION PRODUCED THEREFROM
(FR) COMPRIMÉ DISPERSIBLE CONTENANT DE LA BURLULIPASE ET COMPOSITION PHARMACEUTIQUE OBTENUE À PARTIR DE CE COMPRIMÉ
(DE) SCHMELZTABLETTE ENTHALTEND BURLULIPASE UND DARAUS HERGESTELLTE PHARMAZEUTISCHE ZUSAMMENSETZUNG
Abstract:
(EN) The invention relates to an orodispersible tablet that is characterized in that said orodispersible tablet comprises burlulipase. The invention further relates to liquid pharmaceutical compositions that contain solutions of such orodispersible tablets in water or other beverages. The invention relates to drugs that contain or consist of such orodispersible tablets or solutions. In particular, the invention relates to such drugs that are suitable for treating digestive problems, in particular exocrine pancreatic insufficiency. In particular, said drugs are suitable for treating exocrine pancreatic insufficiency in patients having mucoviscidosis and for treating exocrine pancreatic insufficiency of patients in pediatrics.
(FR) La présente invention concerne un comprimé dispersible caractérisé en ce qu'il contient de la burlulipase. Elle concerne en outre une composition pharmaceutique liquide qui comprend des solutions de tels comprimés dispersibles dans de l'eau ou dans d'autres boissons. L'invention concerne également des médicaments comprenant de tels comprimés dispersibles ou solutions, ou constitués de deux-ci. En particulier, l'invention concerne des médicaments destinés au traitement de troubles digestifs, en particulier de l'insuffisance pancréatique exocrine. Ces médicaments sont en particulier destinés au traitement de l'insuffisance pancréatique exocrine chez les patients atteints de mucoviscidose et de patients en pédiatrie.
(DE) Die vorliegende Erfindung betrifft eine Schnnelztablette die dadurch gekennzeichnet ist, dass sie Burlulipase umfasst. Sie betrifft ferner flüssige pharmazeutische Zusammensetzungen die Lösungen solcher Schmelztabletten in Wasser oder anderen Getränken enthalten. Sie betrifft Arzneimittel die solche Schmelztabletten oder Lösungen enthalten oder daraus bestehen. Insbesondere betrifft sie solche Arzneimittel die zur Behandlung von Verdauungsproblemen, insbesondere exokriner Pankreasinsuffizienz geeignet sind. Insbesondere sind sie zur Behandlung von exokriner Pankreasinsuffizienz bei Patienten mit Mukoviszidose und zur Behandlung von exokriner Pankreasinsuffizienz von Patienten in der Pädiatrie geeignet.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)